A dosimetric algorithm for patient-specific 131I therapy of thyroid cancer based on a prescribed target-mass reduction

Physics in Medicine and Biology

Volumn 51, Issue 24, 2006, Pages 6449-6456

  Traino, A C ^a   Di Martino, F ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHMS; DRUG DOSAGE; MATHEMATICAL MODELS; OPTIMIZATION; PATIENT TREATMENT;

MASS REDUCTION; METASTASIS; METASTATIC CANCERS; REMNANT ABLATION;

TUMORS;

IODINE 131;

ARTICLE; CANCER RADIOTHERAPY; DOSIMETRY; HUMAN; MATHEMATICAL MODEL; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER; TARGET CELL DESTRUCTION; THEORETICAL MODEL; THYROID CANCER; TREATMENT OUTCOME;

ALGORITHMS; COMPUTER SIMULATION; DISEASE PROGRESSION; HUMANS; IODINE RADIOISOTOPES; MODELS, STATISTICAL; MODELS, THEORETICAL; MOLECULAR WEIGHT; NEOPLASM METASTASIS; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECURRENCE; THYROID NEOPLASMS;

EID: 33846882841     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/51/24/011     Document Type: Article

References (20)

1. Bal C S, Kumar A and Pant J S 2004 Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients J. Clin. Endocrinol. Metab. 89 1666-73
2. Chadwick K H and Leenhouts H P 1973 A molecular theory of cell survival Phys. Med. Biol. 18 78-87
3. Dale R G 1985 The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy Br. J. Radiol. 58 515-28
4. Dale R G 1996 Dose-rate effects in targeted radiotherapy Phys. Med. Biol. 41 1871-84
5. Kellerer A M and Rossi H H 1972 The theory of dual radiation action Curr. Top. Radiat. Res. Q. 8 85-158
6. Loevinger R, Budinger T F and Watson E E 1991 MIRD Primer for Absorbed Dose Calculations (New York: The Society of Nuclear Medicine)
7. Maxon H R 1999 Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer Q. J. Nucl. Med. 43 313-23
8. Maxon H R, Englaro E E, Thomas S R, Hertzberg V S, Hinnefeld J D, Chen L S, Smith H, Cummings D and Aden M D 1992 Radioiodine-131 therapy for well-differentiated thyroid cancer: a quantitative radiation dosimetric approach: outcome and validation in 85 patients J. Nucl. Med. 33 1132-6
9. Maxon H R, Thomas S R, Hertzberg V S, Kereiakes J G, Chen I W, Sperling M I and Saenger E L 1983 Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer N. Engl. J. Med. 309 937-41
10. Pacini F 2002 Follow-up of differentiated thyroid cancer Eur. J. Nucl. Med. Mol. Imaging 29 (Suppl. 2) S492-6
11. Rosario P W, Barroso A L, Rezende L L, Padraño E L, Fagundes T A, Reis J S and Purish S 2005 Outcome of ablation of thyroid remnants with 100 mCi (3.7 GBq) iodine-131 in patients with thyroid cancer Ann. Nucl. Med. 19 247-50
12. Rosario P W S, Reis J S, Barroso A L, Rezende L L, Padraño E L and Fagundes T A 2004a Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake Nucl. Med. Comm. 25 1077-81
13. Rosario P W, Maia F F, Cardoso L D, Barroso A, Rezende L, Padraño E L and Purisch S 2004b Correlation between cervical uptake and results of postsurgical radioiodine ablation in patients with thyroid carcinoma Clin. Nucl. Med. 29 358-61
14. Roos D E and Smith J G 1999 Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma: a critique Int. J. Radiat. Oncol. Biol. Phys. 44 493-5
15. Stabin M G 1996a Internal radiation dosimetry Nuclear Medicine vol I ed R E Henkin et al (St Louis, MO: Mosby) pp 316-33
16. Stabin M G 1996b MIRDOSE: the personal computer software for use in internal dose assessment in nuclear medicine J. Nucl. Med. 37 538-46
17. Stabin M G 2006 Nuclear medicine dosimetry Phys. Med. Biol. 51 R187-202
18. Traino A C, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, Mariani G and Lazzeri M 2005 A predictive mathematical model for calculation of the final mass of Graves' disease thyroids treated with 131I Phys. Med. Biol. 50 2181-91
19. Tubiana M, Dutreix J and Wambersie A 1990 Introduction to Radiobiology (London: Taylor and Francis)
20. Zidan J, Hefer E, Iosilevski G, Drumea K, Stein M E, Kuten A and Israel O 2004 Efficacy of 131I ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer Int. J. Radiat. Oncol. Biol. Phys. 59 1330-36